Buzzard Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch Buzzard Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) (NCT06634875) | Buzzard Pharmaceuticals | 2025-01-30 |
| Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors (NCT04121442) | Buzzard Pharmaceuticals | 2020-09-01 |
Track Buzzard Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.